Last Updated: November 19, 2026

Details for Patent: 11,661,604

« Back to Dashboard


Summary for Patent: 11,661,604
Title:Methods and compositions for inhibiting expression of LDHA
Abstract:This disclosure relates to oligonucleotides, compositions and methods useful for reducing LDHA expression, particularly in hepatocytes.
Inventor(s):Bob D. Brown, Henryk T. Dudek, Utsav SAXENA, Natalie PURSELL, Cheng Lai, Weimin Wang, Rachel STORR, Naim Nazef, Boyoung Kim
Assignee: Novo Nordisk Health Care AG
Application Number:US17/022,696
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 11,661,604

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novo RIVFLOZA nedosiran sodium SOLUTION;INJECTION 215842-001 Sep 29, 2023 RX Yes Yes 11,661,604 ⤷  Start Trial Y Y METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) ⤷  Start Trial
Novo RIVFLOZA nedosiran sodium SOLUTION;INJECTION 215842-002 Sep 29, 2023 RX Yes Yes 11,661,604 ⤷  Start Trial Y Y METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) ⤷  Start Trial
Novo RIVFLOZA nedosiran sodium SOLUTION;INJECTION 215842-003 Sep 29, 2023 RX Yes Yes 11,661,604 ⤷  Start Trial Y Y METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,661,604

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2018346971 ⤷  Start Trial
Canada 3078933 ⤷  Start Trial
China 111448319 ⤷  Start Trial
China 118440940 ⤷  Start Trial
China 118530989 ⤷  Start Trial
European Patent Office 3679141 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.